Effectiveness and Safety of Golimumab in Treating Outpatient Ulcerative Colitis: A Real-Life Prospective, Multicentre, Observational Study in Primary Inflammatory Bowel Diseases Centers.

A, Tursi; L, Allegretta; N, Buccianti; Valle N, Della; W, Elisei; G, Forti; R, Faggiani; S, Gallina; Y, Hadad; T, Larussa; A, Lauria; F, Luzza; R, Lorenzetti; G, Mocci; A, Penna; N, Polimeni; G, Pranzo; C, Ricciardelli; C, Zampaletta; M, Picchio

doi:10.15403/jgld.2014.1121.263.trs

Public

Effectiveness and Safety of Golimumab in Treating Outpatient Ulcerative Colitis: A Real-Life Prospective, Multicentre, Observational Study in Primary Inflammatory Bowel Diseases Centers.

Shared by NobleBlocks on Sep 1, 2017 • 12:00 AM UTC

Authors:

Tursi A

Allegretta L

Buccianti N

Abstract

<h4>Background and aims</h4>Golimumab (GOL) has been recently approved in Italy for the treatment of ulcerative colitis (UC) unresponsive to standard treatments. Our aims were to assess the real-life efficacy and safety of GOL in managing UC outpatients in Italian primary Inflammatory Bowel Diseases...

Discussions